Collaboration Details

Print  Close


Title of Collaborative Activity:

FDA Medical Countermeasures initiative (MCMi) Regulatory Science Steering Committee

Description of Collaborative Activity:

This committee provides guidance to Medical Countermeasures initiative (MCMi) stakeholders.

Type of Collaborative Activity:

Meeting/ Workshop

Year the Collaborative Activity Originated:

2012

NIH Participating Institutes/Centers/Office of the Director:

NIAID

HHS Agency Collaborators on this Activity:

FDA